0001485003-20-000018.txt : 20200218 0001485003-20-000018.hdr.sgml : 20200218 20200218171413 ACCESSION NUMBER: 0001485003-20-000018 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200213 FILED AS OF DATE: 20200218 DATE AS OF CHANGE: 20200218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cannell Thomas R CENTRAL INDEX KEY: 0001637822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 20626368 MAIL ADDRESS: STREET 1: C/O SESEN BIO, INC. STREET 2: 245 FIRST STREET, SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 4 1 wf-form4_158206403696552.xml FORM 4 X0306 4 2020-02-13 0 0001485003 Sesen Bio, Inc. SESN 0001637822 Cannell Thomas R C/O SESEN BIO, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 0.8911 2020-02-13 4 A 0 1450000 0 A 2030-02-13 Common Stock 1450000.0 1450000 D On February 13, 2020, the reporting person was awarded options to purchase 1,450,000 shares of the common stock of Sesen Bio, Inc. (the "Company"), which options vest 6.25% every three months over four years provided the reporting person is employed by the Company at each such vesting date. /s/ Thomas R. Cannell 2020-02-13